ENTITY

Seer (SEER US)

13
Analysis
Health Care • United States
Seer, Inc. operates as a biotechnology company. The Company offers solutions which combines proprietary engineered nanoparticles with an automated assay solution to provide an unmatched combination of unbiased, deep, rapid, and scalable workflow to give you a clearer view of the proteome. Seer serves customers in the United States.
more
bullish•Seer
•09 Aug 2026 22:13

Primer: Seer (SEER US) - Aug 2026

Seer is a pre-profitability life sciences company whose stock trades at a significant discount to its cash and investments, reflecting a lack...

Logo
92 Views
Share
x